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Summary.-Conversion of 7a3H-testosterone to 17/3-oestradiol by human mammary
carcinoma tissue in vitro has been demonstrated. It was characterized unequivocally
by conversion to 17/-oestradiol-3-sulphate upon incubation with adenosine-3'-
phosphate-5'-phosphosulphate and the highly specific enzyme oestrogen sulpho-
transferase.
THE ABILITY of human breast tumour
tissue to transform steroids into physio-
logically active hormones endows it with
paraendocrine properties (Adams and
Wong, 1968). Perhaps the most interest-
ing of these properties is the possession of
the aromatase enzyme system this being
so because of the involvement of oestro-
gens in mammary gland growth and
development and in mammary tumouri-
genesis. Evidence for the presence of the
aromatase systemin humanbreasttumours
has been provided by three laboratories;
conversion of 14C-testosterone to oestriol
(Adams and Wong, 1968) or the closely
related 16a-hydroxyoestrone (Dao, Varela
and Morreal, 1972), and the conversion of
3H-dehydroepiandrosterone to oestrone
(Jones et al., 1970). We now wish to
report the conversion of 3H-testosterone
to 17,8-oestradiol. Because of con-
tentious issues which might be raised
concerning the characterization of small
amounts of labelled metabolites by such
methods as co-crystallization with un-
labelled carrier steroid (Jones et al.,
1970; Adams and Wong, 1972), a novel
and unequivocal proof of identity was
achieved by the use of a highly specific
enzyme oestrogen sulphotransferase
(Adams and Low, 1974; Rozhin, Soder-
strom and Brooks, 1974). The labelled
metabolite, obtained in the alkali-soluble
fraction and having chromatographic pro-
perties identical to 17,8-oestradiol, was
converted to awater-soluble sulphateester,
identified as 17,8-oestradiol-3-sulphate,
upon incubation with the enzyme in the
presence ofexcess 3'- phosphoadenosine-5'-
phosphosulphate.
While this report was being prepared,
a paper appeared which also demonstrated
conversion of 3H-testosterone to 17,3-
oestradiol by a human mammary carci-
noma (Miller and Forrest, 1974).
MATERIALS AND METHODS
The patient was an 82-year old woman who
presented in February 1973 with a lump in
the right breast. Biopsy revealed carcinoma
and she was treated with stilboestrol. Some
improvement resulted, the lump gradually
decreasing in size. However in July 1973 the
mass appeared to be increasing, when
stilboestrol was stopped and she was ad-
mitted to hospital in August 1973 for removal
of two lumps by local excision. Palpable
nodes were evident in the right axilla.
Histology revealed anaplastic carcinoma with
numerous mitotic figures and bizarre forms.
Non-malignant mammary ducts and acini
showed considerable hyperplasia. In June
1974 a new mass was evident and a right
radical mastectomy was performed. Medul-
lary carcinoma was diagnosed. Nine of 17
lymph nodes examined showed metastases.
Postoperative recovery was satisfactory andJ. B. ADAMS AND K. LI
the patient is alive and well at the time of
writing.
Tumour tissue was obtained from the
primary site of the mastectomy and was
transported to the laboratory in a balanced-
salt solution at 0°C. The tumour w%Aas
dissected free of fat and a 1-5 g portion finely
minced in 5 ml Krebs/Ringer phosphate,
pH 7-4, containing 1-2 mmol/l NADPH. The
mixture was transferred to a second flask
containing 25 ,uCi of 7CX3H-testosterone
(Radiochemical Centre, S.A. 7-6 Ci/mmol)
dissolved in 0 05 ml of propylene glycol.
Incubation was carried out for 2 h at 37°C in
an atmosphere of 95% 02/5% CO2. The
following carrier steroids (200 ,ug of each)
were then added: oestrone, 17f-oestradiol,
oestriol, 16ao-hydroxytestosterone, 5c-dihy-
drotestosterone, 5ox-androstan-3ca,17/3-diol and
5oa-androstan-3,17-dione. Five vol of acetone
were added and neutral, conjugate and
phenolic fractions isolated by the method of
Fahmy et al. (1968).
The neutral fraction was chromatographed
on silica gel TLC plates (5 x 20 cm) and
developed twice in chloroform acetone (37:
3). One-twentieth of the neutral fraction
was run separately and after chromatography
the 5 x 20 cm plate was placed in a device so
that 0 5 cm segments of Silica gel, from the
origin to solvent front, were scraped auto-
matically into counting vials. Triton-toluene
phosphor (10 ml) (Adams and Poulos, 1967)
was added and samples counted in a Packard
Tricarb 2022 scintillation counter. Marker
steroids were run in parallel and made visible
by spraying with phosphotungstic acid
(Fig. 1). Each ofthe radioactive metabolites
were eluted and subjected to TLC in 3
additional solvent systems. Only one radio-
active peak was obtained in each case and
showed behaviour identical to the com-
panion marker steroids shown in Fig. 1.
Final identification was achieved by the
preparation of 2 derivatives (comprising
oxidation or reduction products, acetates and
Girard hydrazones) for each metabolite and
these in turn were compared with the
authentic derivatives in 3 TLC systems.
The phenolic fraction was chromato-
graphed on silica gel TLC plates and deve-
loped twice in ethyl acetate : cyclohexane
(1 : 1). Part ofthe phenolic fraction was run
separately for monitoring the radioactive
metabolites as described above. The area
corresponding to 17/3-oestradiol was eluted
wNith acetone and after drying dissolved in
chloroform methanol (1 : 1) and chroma-
tographed on a column (1 x 6 cm) of
Sephadex LH-20, developed with the same
solvent. The radioactive fractions were
pooled, dried and the residue chr-omato-
graphed on Whatman 1 paper using a
Zaffaroni system; 20% formamide as sta-
tionary phase and ethyl acetate : butyl
acetate : water (15 : 85 : 5) asmobile phase.
A strip was cut for monitoring the labelled
metabolites. This wNas sectioned into 1 cm
pieces and these w-ere counted directly by
liquid scintillation. An area corresponding
to 17g-oestradiol was eluted with acetone,
and after drying, the residue was dissolved in
0-01 ml of warm propylene glycol. The
following ingredients w%Nere added to provide
an incubation mixture of 0-5 ml: 3'-phospho-
adenosine-5'-phosphosulphate, 0-7 mmol/l;
Tris HCI buffer, pH 7.4, 0-08 mol/l; cysteine
hydrochloride (previously neutralized), 10
mmol/l; MgC12, 5 mmol/l; oestrogen sulpho-
transferase (specific activity 10 m,umol
oestrone sulphate/min/mg (Adams and Low,
1974), 1P5 mg. Incubation AN-as continued for
6 h at 37TC. Water (0 5 ml) was added and
the mixture extracted with ether (3 x 2 ml).
Aliquots were removed for counting and the
aqueous phase was saturated with (NH4)2S04,
made 0-2 mol/l with respect to NH40H, and
extracted with ethyl acetate (3 x 2 ml).
The combined ethyl acetate fraction was
back extracted with 7/8 saturated (NH4)2S04
(0-5 ml) (Dao and Libby, 1968). After
evaporation to dryness, the residue was
dissolved in ethyl acetate (0-2 ml) and an
aliquot chromatographed on Whatman 1
paper developed with 0 4 mol/l potassium
phosphate, pH 65- a system which separates
the 3-sulphate esters of the classic oestrogens
(Payne and Mason, 1963). Markers of
oestrone-3-sulphate and 17/3-oestradiol-3-
sulphate were applied and detected by
Turnbull's reagent after prior hydrolysis in
HCI vapour. A flow-sheet of the above
procedures is show,n in Fig. 2. The polar
metabolite shown on the chromatogram at the
top of Fig. 2 failed to act as a substrate for
oestrogen sulphotransferase.
The conjugate fraction was solvolysed and
chromatographed on silica gel as for the
alkali-soluble fraction. Two metabolites
were present in addition to some contami-
nating testosterone. The major metabolite
was very polar-just moving off the origin,
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Fie. 1. Thin layer chromatographic separation ofmetabolites of 7X3H-testosterone in the " neutral "
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while the minor metabolite had an RF
identical to 17/3-oestradiol. It comprised
only 8% ofthe counts in this fraction and was
not investigated further.
7cX3H-testosterone was incubated without
tissue and processed throughout the above
procedures, to act as a control.
RESULTS
Products identified, after incuba-tion
of 7ax3H-testosterone with the tumour,
are shown in the Table. Conversions are
expressed as a percentage of the total
radioactivity recovered. This was 72.2%
of the counts added and was distributed
as follows: neutral 71%; phenolic 0 34%0;
conjugate 0.84%. Figure 1 shows the
chromatographic separation of the meta-
bolites in the neutral fraction. The sepa-
rate peaks were subsequently found to
consist of one species only and were
identified by comparison with authentic
compounds in a number of chromato-
graphic systems, both as the free sub-
stances and as derivatives.
In Fig. 2 the scheme for the identifica-
tion of 17/]-oestradiol in the alkali-
soluble fraction is shown. The metabolite
with chromatographic properties identical
TABLE. Products Identified by Incubation
of Mammary Carcinoma with 7a3H-
testosterone
Steroid
Testosterone
5ax-Dihydrotestosterone
4-Androstene-3, 17-dione
5nx-Androstan-3cy, 17fl-diol
5x-Androstan-3,17-dione
1 7/-Oestradiol
0 Radioactivity
recovered
60-9
27 0
1 -64
3 -84
1 52
0-07
to those of 17,8-oestradiol acted as a
substrate for oestrogen sulphotransferase.
Partitioning between water and ether
showed that a water-soluble conjugate was
formed which behaved identically to that
of 17,8-oestradiol-3-sulphate on chromato-
graphy. Oestrogen sulphotransferase
sulphurylates exclusively at the 3-position
of phenolic steroids and thus forms the
3-monosulphate with 17,8-oestradiol
(Rozhin et al., 1974; Adams and Poulos,
1967).
DISCUSSION
Formation of 17,-oestradiol by the
breast carcinoma has been demonstrated
unequivocally. The highly purified enzyme
used in its characterization has no action
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Fie. 2.-Flow sheet representing steps employed in the i(lentification of 17fl-oestradliol in the " alkali-
soluble " fraction. T = testosterone. E1 = oestrone. E2 = 17,-oestradiol. E3 = oestriol.
E1S04 = oestrone-3-sulphate. E2SO4 = 17fl-oestradiol-3-sulphate. PAPS = adenosine-3'-
phosphate-5'-phosphosulphate. TLC -thin layer chromatography.
on steroid alcohols such as dehydro-
epiandrosterone, aetiocholanolone, 11-
deoxycorticosterone, 17,-oestradiol-3-
methyl ether, testosterone and preg-
nenolone (Adams and Low, 1974). It
reacts with phenolic steroids with an
hydroxyl group in the 3-position and also
to a limited degree with certain simpler
phenols which possess a hydrophobic side-
chain (Rozhin et al., 1974). Since a
labelled steroid precursor was used, this
latter point is not relevant. Noteworthy
was the high conversion to 5a-dihydro-
testosterone which amounted to 27% of
the label recovered, or some 20% of that
added. Under conditions used in this
experiment, the pathway is seen to be pre-
dominately reductive in that no hydroxy-
lated metabolites were identified. This
was also the experience of Miller and
Forrest (1974), although a much lower
conversion to 5c-dihydrotestosterone
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(167%) and a somewhat higher conversion
to 17f,-oestradiol (0.37%) were reported.
By contrast, formation of hydroxylated
products, e.g. 16a-hydroxytestosterone
from 14C-testosterone (Adams and
Wong, 1968; Dao et al., 1972), and
formation of 16a-hydroxydehydroepi-
androsterone from dehydroepiandro-
sterone (Adams and Wong, 1968) or
dehydroepiandrosterone sulphate (Griffiths
et al., 1972) have been reported. Although
the predominant site for hydroxylation of
both testosterone and dehydroepiandro-
sterone appears to be position 16, both
oestrone and oestradiol can be hydroxy-
lated in the 2-position and subsequently
converted to 2-methoxy derivatives
(Dao et al., 1972; Adams and Wong, 1972;
Melville, 1973).
UJnequivocal demonstration of the
aromatase enzyme system further em-
phasizes the potential paraendocrine be-
haviour of human mammary carcinoma.
Such behaviour, which may not be
exclusive to the tumour but may be shared
by the mammary gland itself, can provide
an explanation for the phenomenon of
hormone independency in mammary
carcinoma, as previously indicated
(Adams and Wong, 1972). Utilization
of circulating steroids such as dehydroe-
piandrosterone sulphate for sex hormone
synthesis, or de novo synthesis of sex
hormones and progestins from cholesterol
(Dao et al., 1972; Adams and Wong,
1972), are conceivable since the appro-
priate enzymes have been demonstrated
in some of these tumours.
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